If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially as antibiotic resistance grows. While it’s currently approved for females ...

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...

The approval of Blujepa was based on results from the phase 3 EAGLE-2 and EAGLE-3 trials, which demonstrated the medication’s noninferiority and superiority, respectively, to nitrofurantoin (one of ...